DOKUMEN123.COM

Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is a type of epithelial lung cancer other than small-cell lung cancer (SCLC). Non-small-cell...

pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC). The drug received breakthrough therapy designation from the US Food and...

overactive NTRK (<1% of NSCLC) by entrectinib or larotrectinib; active RET (around 1% of NSCLC) by selpercatinib. People whose NSCLC is not targetable by...

growth factor receptor-mutated locally advanced or metastatic non-squamous NSCLC in patients who have progressed past tyrosine kinase inhibitor therapy,...

that is approved in China for the treatment of non-small cell lung cancer (NSCLC). The originator of the drug was Shanghai Allist Pharmaceuticals. It is...

medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft...

of ALK-rearranged NSCLC harbour the EML4-ALK fusion, although as of 2020, over 92 fusion partners have been discovered in ALK+ NSCLC. For each fusion partner...

vaccine used to treat cancer, specifically non-small-cell lung carcinoma (NSCLC). CIMAvax-EGF is composed of recombinant human epidermal growth factor (EGF)...

anticancer medication that is used to treat non-small-cell lung cancer (NSCLC). It blocks the activity of anaplastic lymphoma kinase (ALK). It is taken...

(SCLC) and non-small cell lung cancer (NSCLC). This is done because of differing responses to treatment—NSCLC is comparatively less sensitive to chemotherapy...

China, it is approved for the treatment of non-small-cell lung cancer (NSCLC) with MET exon 14 skipping mutations. Hong L, Zhang J, Heymach JV, Le X...

Biotechnology Co., Ltd. for the treatment of non-small-cell lung cancer (NSCLC). It is an epidermal growth factor receptor (EGFR) antagonist. Andamertinib...

cancer (NSCLC). Prior to marketing approval, fulzerasib had received two breakthrough therapy designations, the first for advanced G12C-mutant NSCLC and a...

cancer, including KRAS‑mutant and EGFR‑mutant non–small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Heymach has an h-index of 139 and over...

medication used for the treatment of adults with non-small cell lung cancer (NSCLC). The most common side effects include edema (build-up of fluid), nausea...

carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications. It is taken by mouth. It is mainly used to treating cases of NSCLC that...

prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). It was developed by Novartis and received FDA approval for use in April...

of ALK is a key driver of certain types of non-small cell lung cancer (NSCLC) and neuroblastomas, as well as ALCL. Since ALK is generally not expressed...

PDGFR Idiopathic pulmonary fibrosis (IPF) / non-small cell lung cancer (NSCLC) / ovarian cancer Phase III Afatinib Irreversible ErbB family blocker Breast...

protein, which is found in approximately 13% of non-small cell lung cancer (NSCLC) cases and 1-3% of colorectal cancer cases. The drug binds irreversibly...

(SCC) of the lung is a histologic type of non-small-cell lung carcinoma (NSCLC). It is the second most prevalent type of lung cancer after lung adenocarcinoma...

G12C–Mutated Advanced NSCLC". Onclive. Sternberg, Audrey (January 20, 2022). "Sotorasib Earns Approval in Japan for KRAS G12C+ NSCLC". cancernetwork.com...

participants with previously treated locally advanced or metastatic ROS1-positive NSCLC. The efficacy population included 117 participants; 59 who received one...

radiation treatment work more effectively against brain metastases from NSCLC. It has been shown to potentiate the effects of many chemotherapeutics,...

it is approved for the treatment of advanced non-small cell lung cancer (NSCLC) carrying the KRAS G12C mutation in patients who have received at least...

non-small cell lung cancer (NSCLC). It was approved as monotherapy for the treatment of people with locally advanced or metastatic NSCLC after failure of both...

previously untreated metastatic squamous non-small-cell lung carcinoma (NSCLC). It was counterproductive in non-squamous non-small-cell lung carcinoma...

for the treatment of adults with advanced EGFR T790M mutation positive NSCLC. In December 2025, the Committee for Medicinal Products for Human Use of...

for the treatment of pleural mesothelioma and non-small cell lung cancer (NSCLC). It is available as a generic medication. In February 2004, the U.S. Food...

patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutation. Gumarontinib is a selective MET—hepatocyte...

anti-cancer medication used for the treatment of non-small cell lung carcinoma (NSCLC). Crizotinib inhibits the c-Met/Hepatocyte growth factor receptor (HGFR)...

to be roughly half as common as ALK-rearranged NSCLCs. Similar to ALK-rearranged, ROS1-rearranged NSCLC have younger age of onset and a non-smoking history...

ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not received treatment with ALK inhibitors. Yang Y, Min J, Yang...

studies thus far. In a study in late-stage non-small-cell lung cancer (NSCLC) they found two cases where ctDNA correctly determined the outcome of a...

currently being investigated for the treatment of non-small cell lung cancer (NSCLC), particularly in patients with EGFR mutations. "Asandeutertinib". PatSnap...

in 2024 for locally advanced or metastatic non-small-cell lung cancer (NSCLC) that has epidermal growth factor receptor exon 19 deletion or exon 21 L858R...

used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with mutations in the epidermal growth factor...

non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. Efficacy was evaluated in 81 participants with advanced NSCLC with EGFR exon 20 insertion...

cancer, for example adrenocortical carcinoma and non-small cell lung cancer (NSCLC). This drug was being developed by Pfizer, but they ceased development of...

countries, Argentina and Cuba, for the treatment of recurrent or advanced NSCLC, or NSCLC independent of the disease stage when no other standard therapy can...

studies, and all other Merck-sponsored clinical trials with tecemotide in NSCLC, worldwide. Merck will continue to supply tecemotide for ongoing investigator-sponsored...

features. It is classified as one of several non-small cell lung cancers (NSCLC), to distinguish it from small cell lung cancer which has a different behavior...

main indications for RET inhibitors today are non-small cell lung cancer (NSCLC, which harbors RET fusions in 1-2% of cases), medullary thyroid cancer (MTC...

Angelopoulos PA, et al. (June 2025). "HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs-A Long Way to...

radiation than when treated surgically, while non-small cell lung carcinoma (NSCLC) patients generally did better after surgery, and usually did not respond...

components of any histological variant of non-small cell lung carcinoma (NSCLC) in any relative proportion. In order to ensure that patients receive the...

a first line therapy for NSCLC gave poor results. Interim results on another phase III trial as second-line therapy for NSCLC were completed in 2011. In...

treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients who have undergone progression or recurrence after at least...

Pharmaceutical. In China, it was conditionally approved in 2023 for the treatment of NSCLC and full approval is contingent on results of phase 3 clinical trials. In...

colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer (NSCLC), malignant pleural mesothelioma, and esophageal cancer. It is undergoing[when...

comprehensive meta-analysis of 47 trials and 11,107 patients revealed that NSCLC patients benefit from adjuvant therapy in the form of chemotherapy and/or...

cell lung cancer (NSCLC). It is a spectrum selective tyrosine kinase inhibitor "for the treatment of non-small cell lung cancer (NSCLC) patients with genetic...

evaluated by Shouyao Holdings for the treatment of non-small cell lung cancer (NSCLC). It is an anaplastic lymphoma kinase (ALK) inhibitor. Ficonalkib is a third...

resected solid tumors (melanoma, bladder carcinoma, HPV negative HNSCC, NSCLC, SCLC, MSI-high, or TMB-high cancers). It was also investigated in patients...

for the drug are metastatic breast cancer, non-small cell lung cancer (NSCLC), and head and neck squamous cell carcinoma (HNSCC). Eftilagimod alpha ("efti"...

antibody used for the treatment of metastatic non-small cell lung cancer (NSCLC) in combination with chemotherapy. It is an antineoplastic monoclonal antibody...

was based on a subgroup of 215 participants with ALK-positive metastatic NSCLC, previously treated with one or more anaplastic lymphoma kinase inhibitors...

Administration (NMPA) for the treatment of squamous non-small cell lung cancer (sqNSCLC), extensive-stage small cell lung cancer (ES-SCLC), esophageal squamous...

classified into two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC, the most common of the two types, is a group of cancers...

glandular or squamous differentiation. LCC is categorized as a type of NSCLC (non-small-cell lung carcinoma) that originates from the epithelial cells...

EML4-ALK fusion gene was first reported in non-small cell lung carcinoma (NSCLC) in 2007. The signs and symptoms of this cancer include A cough that doesn't...

relapsed. In 2012, the FDA widened the approved uses to include treatment for NSCLC. In 2013, the FDA approved protein-bound paclitaxel for use in treating...

cell lung cancer (NSCLC) which demonstrated an improvement in PFS, and is now in phase III development in KRAS mutation positive NSCLC (SELECT-1, NCT01933932)...

ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)" (Press release). Xcovery Holdings. 19 December 2024. Retrieved 20 December...

for mutation specific NSCLC patients range between 0% and 8% with tyrosine kinase inhibitors and for non-mutation specific NSCLC patients range between...

PMID 40346420. "Elisrasib Elicits Clinical Benefit in KRASG12C-mutant NSCLC". Cancer Discovery. 16 (6): OF1. June 2026. doi:10.1158/2159-8290.CD-NW2026-0041...

Combos, Targets for NSCLC". Medscape. Retrieved 2020-01-16. "Two New Targeted Therapies Appear Encouraging for Difficult Drivers in NSCLC". Targeted Oncology...

under the category of poorly differentiated non-small-cell lung carcinoma (NSCLC). Based on its histological characteristics, it can be classified into giant...

that is being evaluated for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations, particularly exon 20 insertion mutations. "Zipalertinib...

cell lung cancer (NSCLC) in December 2015, and In South Korea, the drug was approved in May 2016 for the second-line treatment of NSCLC with the T790M mutation...

PARAMOUNT trial is a clinical trial studying non-small-cell lung carcinoma (NSCLC). The trial was sponsored by Eli Lilly and Company and was conducted in...

Vizimpro, is a medication for the treatment of non-small-cell lung carcinoma (NSCLC). It is a selective and irreversible inhibitor of EGFR. Dacomitinib has...

the treatment of various cancers, including non-small cell lung cancer (NSCLC). Eglenen-Polat B, Kowash RR, Huang HC, Siteni S, Zhu M, Chen K, et al....

Enriqueta (1 June 2023). "A phase II trial of JDQ443 in KRAS G12C -mutated NSCLC with PD-L1 expression". Journal of Clinical Oncology. 41 (16_suppl) TPS9158...

2015: Alecensa (alectinib): Treatment for non-small cell lung cancer (NSCLC). 2016: Venclexta (venetoclax): Treatment for patients with chronic lymphocytic...

phosphorylation and has been found to associate with microvessel density in NSCLC. Kinase insert domain receptor has been shown to interact with SHC2, Annexin...

2025. "FDA grants accelerated approval to telisotuzumab vedotin-tllv for NSCLC with high c-Met protein overexpression". U.S. Food and Drug Administration...

trial to investigate its effectiveness against non-small cell lung cancer (NSCLC), in combination with gemcitabine chemotherapy. However, it was discovered...

epidermal growth factor receptor (EGFR) mutated non -small cell lung cancer (NSCLC) who have received prior EGFR- directed therapy and platinum- based therapy...

Learning Center (NSCLC) is a non-profit ecologically sustainable school for high school aged refugee children from Myanmar. The NSCLC is located in the...

cancer (NSCLC), renal cell carcinoma, HER2-negative breast cancer Genentech erlotinib Tarceva Advanced (metastatic) non-small cell lung cancer (NSCLC) Genentech...

melanoma. In October 2023, it was approved by the FDA for treatment of NSCLC with a BRAF V600E mutation in combination with encorafenib. It was developed...

compartment in blood has been associated with a lower risk of relapse in NSCLC treated with perioperative chemoimmunotherapy. In a T-cell dependent development...

resectable (tumors ≥ 4 cm and/or node positive) non-small cell lung cancer (NSCLC) and no known epidermal growth factor receptor (EGFR) mutations or anaplastic...

solid tumor types, including pancreatic cancer, non-small cell lung cancer (NSCLC), and gastric cancer, to test the drug's safety and efficacy. Halozyme has...

resectable (tumors ≥ 4 cm and/or node positive) non-small cell lung cancer (NSCLC) and no known epidermal growth factor receptor (EGFR) mutations or anaplastic...

all studies with KRAS sequencing performed in non-small cell lung cancer (NSCLC). However, KRAS mutations can not only affect the gene itself and the expression...

(T2N0), II (T1-2N1, T3N0) and selected IIIA None Small Cell Lung Cancer (NSCLC) – (RTOGL-0015 (S9900) Memorial Sloan-Kettering Cancer Center Principal...

adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations...

initiated for multiple myeloma, ovarian cancer, hepatocellular carcinoma, and NSCLC, but subsatisfactory results caused research for these indications to be...

licensed for the treatment of breast cancer, non-small cell lung cancer (NSCLC), gastric or gastroesophageal adenocarcinoma. Trastuzumab binds to and blocks...

Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)". Merck.com. Merck & Co., Inc. 2026-05-29. v t e...

carcinoma. As a variant of SqCC, it is considered a non-small cell lung cancer (NSCLC). Both basaloid and squamous cell carcinomas have been shown to arise from...

taletrectinib based on evidence from 270 participants with ROS1-positive NSCLC that had spread beyond the lungs who received taletrectinib 600 mg orally...

Seliciclib is being studied for the treatment of non-small cell lung cancer (NSCLC), Cushing's disease, leukemia, HIV infection, Parkinson's disease, herpes...

It is in phase II trials for patients with non-small-cell lung cancer (NSCLC). This drug was developed by Eli Lilly & Company. World Health Organization...

She lost her husband Matthew to stage four non-small-cell lung cancer (NSCLC) in 2017. Her sister is Croatian-American actress and singer Sanja Matejaš...

differentiate between squamous and non-squamous non-small cell lung cancer (NSCLC); differentiate between adenocarcinoma and peritoneal mesothelioma; and...

treatment of various types of cancer, such as non-small cell lung cancer (NSCLC) and thyroid cancer. The US Food and Drug Administration (FDA) granted the...

be higher than those of other forms of NSCLC. BAC generally carries a better prognosis than other forms of NSCLC, which can be partially attributed to...

2020. Hergert, Jessica (31 January 2021). "Relapsed/Refractory Metastatic NSCLC Tumors Respond to Datopotamab Deruxtecan in Early Trial". Cancer Network...

treatment of adults with ROS1 positive, advanced non small cell lung cancer (NSCLC) not previously treated with ROS1 inhibitors. The common side effects of...

survival following VATS lobectomy compared to open thoracotomy lobectomy for NSCLC. VATS lobectomy does not compromise patient safety or the oncological efficacy...

used to treat locally advanced or metastatic non-small-cell lung cancer (NSCLC), if the cancer cells are positive for the T790M mutation in the gene coding...

2014). "Strategic targeting of the PI3K-NFκB axis in cisplatin-resistant NSCLC". Cancer Biology & Therapy. 15 (10): 1367–77. doi:10.4161/cbt.29841. PMC 4130730...

adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) as detected by an FDA approved test. Efficacy was investigated in a multicenter...

considered a form of non-small cell lung carcinoma (NSCLC), most physicians adhere to published NSCLC treatment guidelines in rhabdoid carcinoma cases....

(GEN1046/BNT311) PD-L1, 4-1BB 50:50 Genmab/BioNTech Non-small-cell lung cancer (NSCLC) II " " " Advanced endometrial cancer II " " " Solid tumors I/II Tecaginlimab...

"Antisoma's Shares Plummet 70% as Cancer Candidate Bombs in Phase III NSCLC Trial". Genetic Engineering & Biotechnology News. 29 March 2010. Archived...

Counties". NSCLC. Archived from the original on 2007-09-28. Retrieved 2007-08-09. Protecting the Rights of Low-Income Older Adults[link removed]. NSCLC. 2010-10-06...

fusion, or people with ROS1-positive advanced non-small cell lung cancer (NSCLC). The applicant for this medicinal product is Bristol-Myers Squibb Pharma...

Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)" at ClinicalTrials.gov Portal: Medicine v t e...

directed antibody drug conjugate, in patients (pts) with EGFR-mutated (EGFRm) NSCLC". Annals of Oncology. 31: S1189–S1190. doi:10.1016/j.annonc.2020.08.2295...

combination with pembrolizumab in patients with KRAS G12C-mutant advanced NSCLC". Journal of Clinical Oncology. 42 (16_suppl): 8510. doi:10.1200/JCO.2024...

prostate cancer, HIV-related Kaposi's sarcoma, non-small cell lung cancer (NSCLC), and breast cancer. These included multiple phase II trials and at least...

medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft...

1056/NEJMoa2027071 "Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC" (ADAURA final OS), New England Journal of Medicine, 2023. doi:10.1056/NEJMoa2304594...

to the drug. After receiving approval from the FDA to study icotinib in NSCLC patients, a phase 1 study was planned to be conducted at Roswell Park Comprehensive...

for miRNA in cancers is to use their expression level for prognosis. In NSCLC samples, low miR-324a levels may serve as an indicator of poor survival...

more active in certain NSCLC variants. Given that c-SCLC contains components of NSCLC, and that the chemoradioresistance of NSCLC components impact the...

sequenced with cemiplimab to treat advanced non-small cell lung cancer (NSCLC) continued in 2024. The trial is a multicentre, open-label, dose-finding...

progressed anti-TIGIT therapy in development. In non-small cell lung cancer (NSCLC) setting, the phase II CITYSCAPE clinical trial (NCT03563716) evaluated...

Biomolecules. 10 (3): 449. doi:10.3390/biom10030449. PMC 7175297. PMID 32183147. METH-2 silencing and promoter hypermethylation in NSCLC Portal: Biology...

trial) and a Phase 2b study (TARGET trial) in non-small-cell lung carcinoma (NSCLC). Temsirolimus (Torisel) Everolimus (Afinitor) Vemurafenib (Zelboraf) Trametinib...

2023. "FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC". U.S. Food and Drug Administration (FDA). 12 December 2022. Archived from...

proven its efficacy in treating adults with non-small-cell lung carcinoma (NSCLC), another form of cancer in which ALK plays a role. The drug is currently...

active in NSCLC cells. Gene expression profiling revealed the prevalence of specific fibroblast growth factors (FGFs) and FGF receptors in NSCLC cell lines...

single-agent activity in previously treated pts with recurrent and advanced NSCLC, with the level of activity similar to currently approved agents.” In a...

for BRAF V600-positive advanced or metastatic non small-cell lung cancer (NSCLC). In September 2023, the Committee for Medicinal Products for Human Use...

indicated for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation and who have progressed after at least one prior...

BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR)...

cancer, traditionally classified within the non-small-cell lung carcinomas (NSCLC). The characteristic feature of this highly lethal malignancy is the distinctive...

(April 2014). "Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC". Cancer Treatment Reviews. 40 (3): 445–456. doi:10.1016/j.ctrv.2013.08...

directed antibody drug conjugate, in patients (pts) with EGFR-mutated (EGFRm) NSCLC". Annals of Oncology. 31: S1189–S1190. doi:10.1016/j.annonc.2020.08.2295...

+ Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC (DUBLIN-3), Phase Three". clinicaltrials.gov. 2021-05-23. Retrieved 2024-07-19...

first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) mutation BCR-ABL...

lymphoma (DLBCL), histological classification of nonsmall-cell lung cancer (NSCLC), evaluation of results of immunotherapy agents, and assessment of the genes'...

antiinflammatory drug NSBB Non-selective beta blocker NSCC Non-squamous-cell carcinoma NSCLC non–small cell lung carcinoma NSD normal spontaneous delivery (see childbirth)...

Naïve Stage IIIB/IV Non-Squamous Cell Histology Non-Small Cell Lung Cancer (NSCLC)" at ClinicalTrials.gov "Search of: CA4P - List Results - ClinicalTrials...

cancer (NSCLC) models. In preclinical studies, the drug reduced mTORC1 activity, leading to robust inhibition of tumor growth in mice with NSCLC xenografts...

cancer, triple-negative breast cancer and in non-small cell lung cancer (NSCLC). Pamiparib (BGB-290) For ovarian cancer, the 1st patient enrolled in May...

Health Systems. HS-110, also called viagenpumatucel-L, is in Phase II in NSCLC, in combination with cyclophosphamide. Another Phase I study is combining...

patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations...

clinically active in platinum-resistant and -sensitive ovarian cancer, NSCLC, prostate cancer, glioblastoma and melanoma. "Sagopilone". pubchem.ncbi...

combined with letrozole Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients completed...

longer survival of NSCLC-bearing mice, suggesting that RPN2 may represent a promising new target for RNAi-based medicine against NSCLC. Similar potential...

Penpulimab for First-line Treatment of Locally Advanced or Metastatic Squamous NSCLC". Akeso (Press release). Song Y, Zhou K, Jin C, Qian Z, Hou M, Fan L, et al...

example, the EGFRm inhibitor osimertinib for non-small cell lung cancer (NSCLC), is now approved in over 75 countries. Pangalos is on the AstraZeneca Senior...

technique with tissue samples from patients with non-small cell lung cancer (NSCLC) and found excess phosphorylation in the tumor cell lines and surveyed tyrosine...

"Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC". Expert Opinion on Pharmacotherapy. 16 (8): 1245–53. doi:10.1517/14656566...

by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade". Cancer Discovery. 16 (6): 1152–1175. doi:10...

MCACL has been traditionally considered a non-small cell lung carcinoma (NSCLC). Complete radical surgical resection is the treatment of choice. There...

outcomes to immunotherapy. In the context of non-small cell lung cancer (NSCLC), BCR metrics obtained through sequencing of both tumour tissue and peripheral...

immunotherapy and poor clinical outcomes, especially in non-small cell lung cancer (NSCLC). High circulating levels of CXCL13 often reflect a dysregulated peripheral...

Drop-Seq was used to determine cell-to-cell differences in EGFR-mutated NSCLC, revealing that this variability influences treatment responses. It was...

trial) and a Phase 2b study(TARGET trial) in non-small-cell lung carcinoma (NSCLC) are ongoing (in 2012). A Marketing Authorization Application (MAA) filing...

with paclitaxel as a chemotherapy regimen in non-small cell lung cancer (NSCLC) adenocarcinomas. Lipoplatin evades immune surveillance thus escaping clearance...

Valley 73% 20% Esophageal 73% 27% Head and neck squamous cell carcinoma (HNSCC) 31%-33% 20%-25% Non-small cell lung cancer (NSCLC) 69% 72% Colorectal 10%...

Non-small-cell lung cancer (NSCLC): The MIR22HG gene was down-regulated (i.e. under-expressed to give low levels of this genes lncRNA) in the NSCLC tumors of individuals...

combination with amivantamab, for the treatment of non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) exon 19 deletions...

further treated. ERCC1-positive NSCLC tumors do not benefit from adjuvant platinum chemotherapy. However, ERCC1-negative NSCLC tumors, prognostically worse...

"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells". Nature. 595 (7868): 578–584. Bibcode:2021Natur.595..578C. doi:10...

factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, which progressed on or after EGFR...

Via Intradermal Injection in Patients With Non-small Cell Lung Cancer (NSCLC) in the Advanced and Adjuvant Settings". {{cite journal}}: Cite journal...

had been in a Phase III clinical trial for non-small cell lung cancer (NSCLC), a Phase II/III trial for breast cancer, a Phase II trial for pancreatic...

currently undergoing Phase II clinical trials for non-small-cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), acute myeloid leukemia /myelodysplastic...

Newsroom". news.bms.com. "FDA Expands Approved Use of Nivolumab to Squamous NSCLC - ESMO". www.esmo.org. Pierson, Ransdell (2009-07-23). "Bristol-Myers to...

development of the ALK inhibitor crizotinib (Xalkori), FDA-approved for NSCLC in 2011. Sugen also generated extensive basic research on kinase biology...

(for NSCLC) concluded : "The addition of PX-866 to docetaxel did not improve PFS, response rate, or OS in patients with advanced, refractory NSCLC without...

advanced solid tumours and NSCLC. A placebo-controlled phase III study, examining overall survival in patients with advanced NSCLC treated with AMG 706 in...

ALK-positive metastatic NSCLC". FDA.[dead link] "BRIEF-Takeda Says European Commission Approved Alunbrig As A First-Line Treatment For ALK+ NSCLC". Reuters. 2020-04-06...

effectiveness against advanced nonsquamous non-small-cell lung cancer (NSCLC), with Phase II trials indicating an effectiveness comparable to bevacizumab...

2018, de la Houssaye was diagnosed with EGFR+ non-small-cell lung cancer (NSCLC), although an athlete who did not smoke or drink alcohol and had regular...

tyrosine kinase inhibitor, demonstrates robust activity in RET fusion positive NSCLC patients". Cancer Research. 83 (8_Supplement) CT201. doi:10.1158/1538-7445...

PMC 7941985. PMID 33750378. "Tác dụng kháng ung thư phổi không tế bào nhỏ (NSCLC) của Aspiletrein A, saponin steroid từ loài Aspidistra letreae". Khoa Dược...

II trials in both Non-Small Cell Lung cancer and Brain Metastases from NSCLC. In Canada, in June 2007, the company received clearance from Health Canada...

resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition". Free Radical Biology & Medicine...

adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR-exon 19 deletions or exon 21 L858R substitution mutations. A...

people with wild-type BRAF melanoma, wild-type BRAF CRC, or wild-type BRAF NSCLC. In December 2024, the FDA granted accelerated approval to encorafenib with...

PMC 3109235. PMID 21457778. "RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma)". Retrieved 6 October 2014. "RTA 408 Ophthalmic Suspension for...

EMECL is relatively good, and considerably better than most other forms of NSCLC. The skull and dura are possible sites for metastasis from pulmonary EMC...

over-expressed in non-small-cell lung carcinoma (NSCLC), and at an even higher level in metastatic lymph nodes of NSCLC. Deficiency in XRCC1, due to being heterozygous...

ligand. HER2 mutations have been found in non-small-cell lung cancers (NSCLC) and can direct treatment. HER2 is the target of the monoclonal antibody...

Short-Term Recurrence of Surgical Patients with Non-small Cell Lung Cancer (NSCLC). pp. 47–55. Issues in Gastroenterology and Hepatology: 2011 Edition. ScholarlyEditions;...

series or case reports. In many cases, SCL are generally treated like other NSCLC. However, as SCL are considered particularly aggressive non-small cell lung...

Jiangsu Hansoh Pharma for Aumolertinib, a third-generation GFR-TKI to treat NSCLC". www.pharmabiz.com. Retrieved 6 March 2026. "Glenmark Telma's journey to...

– Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC (feasibility). Radiosensitivity Radiogenomics Radiation therapy Personalized...

An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC". Oncotarget. 7 (48): 79526–79543. doi:10.18632/oncotarget.12755. PMC 5346733...

HeLa Cervical cancer 3.0±0.4 PA-1 Ovarian teratocarcinoma 1.4±0.1 LB37-1 NSCLC LB85 SCLC 3.4±0.2 LB92 SCLC 0.6±0.2 LB1047 Renal cell carcinoma 0.8±0.2...

plus atezolizumab (atezo) in patients with non–small cell lung cancer (NSCLC)—A randomized, double-blind trial". Journal of Clinical Oncology. 40 (16_suppl)...

deeper layers. Phase II Advanced breast cancer Non-small cell lung cancer (NSCLC) Multiple myeloma Advanced melanoma Phase III A comparison of dinaciclib...

was approved by FDA for advanced (metastatic) non-small cell lung cancer (NSCLC) patients whose disease has progressed after other treatments. Toripalimab...

Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. At diagnosis, almost 70% of persons with NSCLC have locally advanced or...

(NSCLC). Similarly to the pancreatic cancer trial, the hTERT peptide vaccine showed to be well tolerated and safe. This study demonstrated that NSCLC patients...

proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC". J. Proteome Res. 12 (7): 3423–33. doi:10.1021/pr400273z. PMID 23713811...

(PTC) where they represent 10-20% of cases, and non-small cell lung cancer (NSCLC) where they represent 2% of cases. Several fusion partners have been described...

microenvironment might be developed for cancer therapy. In non-small-cell lung cancer (NSCLC) tissues, researchers found an association between expression of MARCO mRNA...

Levitan, Dave (10 October 2018). "Can Surgery Type Predict Opioid Abuse in NSCLC?". cancernetwork.com. Retrieved 27 January 2019. Levitan, Dave (12 July...

Shaw MW, et al. (2004). "METH-2 silencing and promoter hypermethylation in NSCLC". Br. J. Cancer. 91 (6): 1149–54. doi:10.1038/sj.bjc.6602107. PMC 2747718...

therapy in patients (pts) with stage IIIb/IV non-small cell lung cancer (NSCLC). - ASCO 2010; Abstract 7588; A phase I pharmacodynamic and pharmacokinetic...

TCIA users. For example, doi:10.7937/K9/TCIA.2015.L4FRET6Z describes the NSCLC-Radiomics-Genomics Collection. In the lower section of the page there are...

Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) (INSIGHT)". clinicaltrials.gov. 13 October 2022. Paik, Paul K.; Felip,...

associated with tumor progression during EGFR-targeted therapy for patients with NSCLC". Theranostics. 10 (12): 5181–5194. doi:10.7150/thno.44693. PMC 7196290...

T790M-mediated drug resistance in vitro and in vivo in non-small cell lung cancer (NSCLC). In HNSCC mutations of the AJUBA mediate sensitivity to treatment with...

for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study" (Press release)...

regarded as promising therapy to NSCLC. As can be seen in the above, SFRP1 was downregulated epigenetically in NSCLC and was recently proposed as one...

to drive tumorigenesis in STK11(LKB1)-null non-small cell lung cancers (NSCLC). CRTC2 has been shown to interact with SNF1LK2 and YWHAQ. GRCh38: Ensembl...

naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)" at ClinicalTrials.gov Clinical trial number NCT00945191 for "Combination...

vinorelbine, significantly inhibits tumor growth and prolongs survival in NSCLC. These findings suggest that combining oblimersen with other chemotherapeutic...

WT1 Melanoma MART-1, gp100, and tyrosinase Non small lung cell cancer (NSCLC) URLC10, VEGFR1, and VEGFR2 Ovarian cancer survivin Pancreatic cancer MUC1...

gene is responsible for approximately 3–5% of non-small-cell lung cancer (NSCLC). The vast majority of cases are adenocarcinomas. Patients with this ALK...

cancer, and hepatocellular carcinoma. Under the European Union approval, NSCLC therapy with ramucirumab is contraindicated when there is tumor cavitation...

response against the tumor. In the context of non-small cell lung cancer (NSCLC) treated with neoadjuvant chemoimmunotherapy, a higher proportion of Tfh...

colorectal cancer, gastrointestinal cancer, and non-small cell lung cancer (NSCLC). Since GPBB is upregulated during the potential transition of adenoma cells...

Prostate cancer (copy number variant) Colorectal cancer (CAD-ALK gene) NSCLC (EGFR and KRAS mutations) Gastric cancer (EGFR mutations) Nasopharyngeal...

advanced non-small-cell lung cancer (NSCLC) and advanced colorectal cancer. Stable disease was observed in a number of NSCLC patients. In two phase 1b clinical...

(FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC). Journal of Experimental & Clinical Cancer Research 2008, 27, 52.) . Gallagher...

Zhao G, Zhang G (2014). "MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3". Tumour Biol. 35 (4): 3487–94. doi:10.1007/s13277-013-1460-1...

a drug manufactured by Astellas, was approved by the U.S. FDA to treat NSCLC patients with tumors caused by mutations of EGFR. The binding of erlotinib...

malignancies. CASS4 function was linked to non-small cell lung cancer (NSCLC) in a study by Miao et al. that correlated elevated CASS4 expression with...

Kislinger T, Tsao MS, Moran MF (July 2015). "CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration". Mol. Cancer Res...

human non-small-cell-lung cancer (NSCLC); and in clinical studies showing improved survival in female cases of NSCLC that were carriers of two known reduction...

surgery for overall and progression-free survival in operable stage IA NSCLC, offering a less toxic option without compromising survival, though its...

immunotherapy. it has Breakthrough Therapy Designation for EGFR-mutated NSCLC. GRCh38: Ensembl release 89: ENSG00000184292 – Ensembl, May 2017 GRCm38:...

for use in patients with a specific type of non-small cell lung cancer (NSCLC; ALK-positive), a type of cancer which often metastasizes to the brain,...

aberrant methylation of the ATM gene promoter. In non-small cell lung cancer (NSCLC), the ATM promoter methylation status of paired tumors and surrounding histologically...

"Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC". J. Exp. Clin. Cancer Res. 30 (1): 18. doi:10.1186/1756-9966-30-18. PMC 3045976...

with Vemurafenib (BRAF) Crizotinib ALK/Met Pfizer Small molecule 2011 Aug (NSCLC with Alk mutation) Cabozantinib RET/MET/VEGFR2 Exelixis Small molecule 2012...

"Phase I trial of 5-azacitidine (5AC) and SNDX-275 in advanced lung cancer (NSCLC)". Journal of Clinical Oncology. 26 (15_suppl): 19036–. doi:10.1200/jco...

growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells". Oncotarget. 8 (28): 45432–45446. doi:10.18632/oncotarget.17139....

2022). "Efficacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial". Journal of Thoracic...

"Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC)". Journal of Clinical Oncology. 33 (15_suppl) e22245. doi:10.1200/jco.2015...

PI3K/Akt/mTOR pathway on biological characteristics and chemosensitivity of NSCLC A549/DDP cells". Oncology Letters. 22 (2): 584. doi:10.3892/ol.2021.12845...

inoperable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC) in certain situations, as a first-line treatment for metastatic bladder...

papillary bladder cancer 42% High grade papillary bladder cancer 65% Non-small cell lung cancer (NSCLC) 70% NSCLC Stage I 62% NSCLC Stages II-III 77%...

overexpression of WNT1 has been identified in non-small cell lung cancer (NSCLC) and correlates with increased tumor proliferation, angiogenesis, and a...

Yangling; Zhang, Bo; Lin, Nengming (2024). "SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization". Redox...

of melanoma, renal cell carcinoma (RCC), and non-small-cell lung cancer (NSCLC) with some degree of success. This is accomplished through the blocking...

In a study of MSH2 in non-small cell lung cancer (NSCLC), no mutations were found while 29% of NSCLC had epigenetic reduction of MSH2 expression. In acute...

2-year EFS and 2-year OS. In patients with non-small cell lung cancer (NSCLC), higher CD99 expression in the stroma results in better prognosis. There...

neck squamous cell carcinomas (HNSCC) and non-small-cell lung cancers (NSCLC) as well as in other tumor types, but with no identified tumor suppressor...

(NMPA) for the treatment of non-squamous non-small cell lung cancer (nsqNSCLC) . In December 2023, the Indonesian Food and Drug Authority approved serplulimab...

emphasis on the most common type of lung cancer, non-small cell lung cancer (NSCLC). These techniques have been reviewed extensively and have attained substantial...

(April 2014). "Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC". Cancer Treatment Reviews. 40 (3): 445–456. doi:10.1016/j.ctrv.2013.08...

was carried out on 493 histology or cytology-confirmed stage IIIB and IV NSCLC patients with a life expectancy >3 months. Patients were treated with Endostar...

receptor (EGFR) mutated non-small cell lung cancer (NSCLC) as well as inoperable stage III NSCLC. In March 2015, a CureVac investor, the Bill & Melinda...

tissue samples from resected stage I - III non-small-cell lung carcinoma (NSCLC). An electronic database (termed iBiobank) is used to store the anonymized...

An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC". Oncotarget. 7 (48): 79526–79543. doi:10.18632/oncotarget.12755. PMC 5346733...

cancer from malignant pleural mesothelioma, non-small cell lung cancer (NSCLC), or breast cancer. In this trial GL-ONC1 infection of tumor cells was identified...

Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)" at ClinicalTrials.gov Clinical trial number NCT03969004 for "Study of...

(2025). "The Therapeutic Significance of HER3 in Non-small Cell Lung Cancer (NSCLC): A Review Study". Current Medicinal Chemistry. 32 (3): 434–446. doi:10...

cancer (TNBC), acute myeloid leukemia (AML), non-small-cell lung cancer (NSCLC), pancreatic cancer and ovarian cancer, among others. Axl was first isolated...

BA, Li F, Hao JJ, Shan X, et al. (October 2020). "Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression...

PK/PD and preliminary clinical activity in certain tumor types such as NSCLC, breast, ovarian endometrial cancer. Preclinical data demonstrate that these...

is present in 9 to 22% of patients with non-small-cell lung carcinoma (NSCLC). FGFR1 amplification was highly correlated with a history of tobacco smoking...

small cell lung carcinoma (NSCLC) which accounts for 85% of all lung cancer cases in the United States. Individuals with NSCLC are often treated with therapeutic...

not confirm superiority over standard care. Non-small cell lung cancer (NSCLC): Phase 2 data with paclitaxel showed encouraging response rates in taxane-pretreated...

solid tumors or leukemias and phase II with non-small-cell lung carcinomas (NSCLC). In a Phase II clinical trial for use of Edelfosine in treating leukemia...

GL, Gao B, Nishizaki M, et al. (2003). "CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling...

2025. "FDA grants accelerated approval to telisotuzumab vedotin-tllv for NSCLC with high c-Met protein overexpression". U.S. Food and Drug Administration...

of patients with advanced non-squamous (NSq) non-small cell lung cancer (NSCLC) detectable via IHC (immunohistochemistry). Cluster of differentiation GRCh38:...

2016. "FDA Requests Additional Data for Rociletinib in EGFR T790M-Mutant NSCLC". OncLive. November 16, 2015. Retrieved January 4, 2016. Investors doubt...

3d (2d Cir. 2010) Martinez v. Astrue settlement, available at http://www.nsclc.org/wp-content/uploads/2011/06/Martinez-v-Astrue-Settlement-Agreement.pdf...

between the lnRNA and epithelium/mesenchyme. In non-small cell lung cancers (NSCLC), researchers found that HOXA11-AS plays a role as an oncogene, and that...

Kinase Inhibitor (EGFR-TKI) for the Treatment of Non-Small Cell Lung Cancer (NSCLC)". Australian New Zealand Clinical Trials Registry. Potter BV (August 2018)...

miR-15a and miR-16 function in tumorigenesis of non-small cell lung cancer (NSCLC) cell lines. miRNA biosensors also have a significant role in the elucidation...

elotuzumab (NCT02252263), nivolumab (NCT02253992) for metastatic solid tumors, NSCLC, melanoma, B-cell non-Hodgkin lymphoma, colorectal cancer, and multiple...

cancer as well, especially in metastatic non-small-cell lung carcinoma (NSCLC). There are a variety of drugs used for cancer treatment. Vinorelbine is...

Versus Placebo in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Treated With Docetaxel in the 2nd/3rd Line Setting (PRESERVE 4)". {{cite...

Including vorinostat in treatment of advanced non-small-cell lung carcinoma (NSCLC) showed improved response rates and increased median progression free survival...

to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy". Journal for ImmunoTherapy...

Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy". Clinical Cancer Research. 27...

(May 2017). "A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC". Sci Rep. 7 (1) 1900. Bibcode:2017NatSR...7.1900S. doi:10...

Harris CC, Yang P, Jen J (July 2012). "Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never...

Bianco C, Pham T, et al. (July 2014). "CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance". The Journal of Clinical Investigation...

glioblastoma multiforme and anaplastic astrocytoma), non-small cell lung cancer (NSCLC), adrenocortical carcinoma, various sarcomas, head and neck squamous cell...

Guoqiang (2017). "Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1". Oncology Reports...

(1999), "Long term complete response in patient with advanced, localized NSCLC with hydrazine sulfate, radiation and Carboplatin, refractory to combination...

observed with approximately 2 to 25% of non-small cell lung carcinoma (NSCLC) patients. Some studies have shown a negative correlation between the effectiveness...

(April 2014). "Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC". Cancer Treatment Reviews. 40 (3): 445–456. doi:10.1016/j.ctrv.2013.08...

cancer, multiple myeloma, neuroendocrine tumors, non-small cell lung cancer (NSCLC), pancreatic cancer, and solid tumors. Adverse effects of Dalotuzumab: Infusion-related...

PMID 16461907. "Vebreltinib Receives Approval in China For MET Exon 14+ NSCLC". onclive.com. 16 November 2023. Matsumoto K, Nakamura T (April 2003). "NK4...

400 mutations per megabase of genome. It has been shown that melanoma, NSCLC and other squamous carcinomas have the highest levels of TMB in this order...

of life and survival rates in patients with non‐small cell lung cancer (NSCLC). The results of the article were discussed outside of academic circles...

demonstrated the utility of radiomics for predicting immunotherapy response of NSCLC patients using pre-treatment CT and PET/CT images. Radiomics remains inferior...

Networking, Health 2.0, and Trust 11 December 2008 Perceptions of stage IV NSCLC patients and caregivers regarding severity of symptoms and willingness to...

methylation correlates with immune infiltration and prognostic value in NSCLC". Frontiers in Genetics. 13 937069. doi:10.3389/fgene.2022.937069. ISSN 1664-8021...

hepatocellular carcinoma, metastatic melanoma and non-small cell lung cancer (NSCLC). Sunitinib is an oral drug that inhibits the phosphorylation of all the...

This process has been proved in melanoma and non-small cell lung cancer (nsclc) cells. Accordingly, we can conclude that USP27X can act as a tumour suppressor...

Kinase Inhibitor (EGFR-TKI) for the Treatment of Non-Small Cell Lung Cancer (NSCLC)". Australian New Zealand Clinical Trials Registry. Archived from the original...

division of lung cancers into SCLC and non-small cell lung carcinomas (NSCLC), with the former being treated primarily with chemoradiation, and the latter...

improved clinical outcomes in KRASG12C-mutated non-small-cell lung cancer (NSCLC) in response to sotorasib treatment. NK2 homeobox 1 has been shown to interact...

complete lack thereof) in cancer tissues such as non-small cell lung cancer (NSCLC), colon cancer, etc. Moreover, in certain cancers like breast cancer, there...

have lower survivals. Addiction to XDH protein has been used to target NSCLC tumors and cell lines in a precision oncology manner. Aldehyde oxidase and...

Valley 73% 20% Esophageal 73% 27% Head and neck squamous cell carcinoma (HNSCC) 31–33% 20–25% Non-small cell lung cancer (NSCLC) 69% 72% Colorectal 10%...

(NCT05835570) involving 58 participants with non-small cell lung cancer (NSCLC) compared the diagnostic performance of 68Ga-Trivehexin PET/CT with 18F-FDG...

S, Zheng Y, Wang QE (October 2016). "DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses". Tumour Biology. 37 (10): 14183–14191...

the treatment of microinvasive endobronchial non-small-cell lung cancer (NSCLC) in patients for whom surgery and radiotherapy are not indicated and also...

carcinoma Overexpression Melanoma Overexpression Non-small cell lung carcinoma (NSCLC) Expression associated with metastasis Endometrial cancer Overexpression...

carcinoma, cutaneous squamous carcinoma, non-small cell lung carcinoma (NSCLC), ovarian cancer, pancreatic cancer, colorectal cancer correlates with downregulation...

of EGFR1, a marker indicating a patient's non-small-cell lung carcinoma (NSCLC) will likely respond to gefitinib or erlotinib treatment. Cancer biomarkers...

Zhang G (Apr 2014). "MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3". Tumour Biology. 35 (4): 3487–94. doi:10.1007/s13277-013-1460-1...

Mellert H, Pestano G (5 Jun 2017). "Adoption of Liquid Biopsy Tests for NSCLC". Retrieved 24 July 2019. Sacher AG, Paweletz C, Dahlberg SE, Alden RS,...

histology. Diagnostic assay can provide highly accurate subclassification of NSCLC patients. Mir-205 has been found to be significantly deregulated in colorectal...

enrolled in the study all of which had a form of non-small cell lung cancer (NSCLC), a median age of 57, most diagnosed as level III & IV of disease progression...

increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC". Journal of Experimental & Clinical Cancer Research. 35 (1) 158. doi:10...

parenchyma – nolatrexed – non-Hodgkin's lymphoma – non-small cell lung cancer (NSCLC) – nonconsecutive case series – noncontiguous lymphoma – nonhematologic...

several solid tumors such as Breast, Colorectal, Non-Small Cell Lung Cancer (NSCLC), Prostate, Melanoma, Bladder, and Pancreatic cancer. New research uses...

antifolate". Mesotheliomaweb.org. Retrieved 23 June 2018. "Advanced NS NSCLC Treatment - ALIMTA (pemetrexed for injection)". Alimta.com. Retrieved 23...

When 8 DNA repair genes were evaluated in non-small cell lung cancer (NSCLC) tumors, 42% were hypermethylated in the NEIL1 promoter region. This was...

SY (Feb 2008). "[Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes]". Zhonghua Zhong Liu Za Zhi [Chinese...

cell cycle arrest than TAZ. When assayed in non-small-cell lung cancer (NSCLC) cell lines, WWTR1 maintained the extracellular matrix (ECM) organization...

the late secretory phase. In a study using non-small cell lung cancers (NSCLC), c-jun was found to be overexpressed in 31% of the cases in primary and...

promoter methylation in a small proportion of non-small cell lung cancer (NSCLC) tumours. RAD23B appears to be one of 26 DNA repair genes that are epigenetically...

at preventing progression of large metastatic tumors in mouse models of NSCLC. Even though Opn promotes metastasis and can be used as a cancer biomarker...

across multiple types of cancer (e.g., melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma, etc.). Checkpoint inhibitor drugs have seen growth...

some cancers, and suppresses tumor growth of non-small-cell lung cancer (NSCLC) cells, endometrial adenocarcinoma cells, and in melanoma cells. GRCh38:...

When 8 DNA repair genes were evaluated in non-small cell lung cancer (NSCLC) tumors, 42% were hypermethylated in the NEIL1 promoter region. This was...

chemotherapies such as paclitaxel and cisplatin in non-small-cell lung cancer (NSCLC) is strongly associated with overexpression of beta III tubulin. Investigations...

S2CID 28490341. Hirabayashi H (May 2002). "[P27 expression and survival in NSCLC]". Nihon Rinsho. Japanese Journal of Clinical Medicine. 60 Suppl 5 (Suppl...

When 8 DNA repair genes were evaluated in non-small cell lung cancer (NSCLC) tumors, 42% were hypermethylated in the NEIL1 promoter region. This was...

Retrieved 2018-03-27. "FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC". fda.gov. 2019-08-16. Archived from the original on September 28, 2019...

Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)". PLOS ONE. 11 (2) e0150197. Bibcode:2016PLoSO..1150197S. doi:10.1371/journal...

"MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration". International Journal of Cancer. 129 (11):...

strongly with the severity of tumor infiltration by inflammatory cells in NSCLC patients. (pg. 6) — This links RelA activation, and promoter methylation...

which are frequently altered in tumor cells. In non-small cell lung cancer (NSCLC) cells, inhibition of SLC25A10 was found to increase the sensitivity to...

Sha Z, Zheng X, et al. (July 2015). "miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion". Acta Biochimica et Biophysica...